A LIN28B polymorphism predicts for colon cancer survival

Cancer Biology and Therapy

Volumn 13, Issue 14, 2012, Pages 1390-1395

  Ye, Yuanqing ^a   Madison, Blair ^b   Wu, Xifeng ^a   Rustgi, Anil K ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Colon cancer; Genetics; Genomics; LIN28B; Molecular pathogenesis; Prognosis; SNP

Indexed keywords

BIOLOGICAL MARKER; LIN28B PROTEIN; PROTEIN DERIVATIVE; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CHROMOSOMAL INSTABILITY; COLON CANCER; COLORECTAL CANCER; FEMALE; GENETIC IDENTIFICATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; SINGLE NUCLEOTIDE POLYMORPHISM;

COLONIC NEOPLASMS; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA-BINDING PROTEINS;

EID: 84870670280     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.22336     Document Type: Article

References (24)

1. Moss EG, Lee RC, Ambros V. The cold shock domain protein LIN-28 controls developmental timing in C. elegans and is regulated by the lin-4 RNA. Cell 1997; 88:637-46; PMID:9054503; http://dx.doi.org/10.1016/S0092-8674(00)81906-6.
2. Mayr F, Schütz A, Döge N, Heinemann U. The Lin28 cold-shock domain remodels pre-let-7 microRNA. Nucleic Acids Res 2012; 40:7492-506; PMID:22570413; http://dx.doi.org/10.1093/nar/gks355.
3. Nam Y, Chen C, Gregory RI, Chou JJ, Sliz P. Molecular basis for interaction of let-7 microRNAs with Lin28. Cell 2011; 147:1080-91; PMID:22078496; http://dx.doi.org/10.1016/j.cell.2011.10.020.
4. Piskounova E, Polytarchou C, Thornton JE, LaPierre RJ, Pothoulakis C, Hagan JP, et al. Lin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct mechanisms. Cell 2011; 147:1066-79; PMID:22118463; http://dx.doi.org/10.1016/j. cell.2011.10.039.
5. Ong KK, Elks CE, Li S, Zhao JH, Luan J, Andersen LB, et al. Genetic variation in LIN28B is associated with the timing of puberty. Nat Genet 2009; 41:729-33; PMID:19448623; http://dx.doi.org/10.1038/ng.382.
6. Sulem P, Gudbjartsson DF, Rafnar T, Holm H, Olafsdottir EJ, Olafsdottir GH, et al. Genome-wide association study identifies sequence variants on 6q21 associated with age at menarche. Nat Genet 2009; 41:734-8; PMID:19448622; http://dx.doi.org/10.1038/ng.383.
7. Perry JR, Stolk L, Franceschini N, Lunetta KL, Zhai G, McArdle PF, et al. Meta-analysis of genome-wide association data identifies two loci influencing age at menarche. Nat Genet 2009; 41:648-50; PMID:19448620; http://dx.doi.org/10. 1038/ng.386.
8. He C, Kraft P, Chen C, Buring JE, Paré G, Hankinson SE, et al. Genome-wide association studies identify loci associated with age at menarche and age at natural menopause. Nat Genet 2009; 41:724-8; PMID:19448621; http://dx.doi.org/10.1038/ng.385.
9. Viswanathan SR, Powers JT, Einhorn W, Hoshida Y, Ng TL, Toffanin S, et al. Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet 2009; 41:843-8; PMID:19483683; http://dx.doi.org/10. 1038/ng.392.
10. Saiki Y, Ishimaru S, Mimori K, Takatsuno Y, Nagahara M, Ishii H, et al. Comprehensive analysis of the clinical significance of inducing pluripotent stemness-related gene expression in colorectal cancer cells. Ann Surg Oncol 2009; 16:2638-44; PMID:19554373; http://dx.doi.org/10.1245/s10434-009-0567-5.
11. Peng S, Maihle NJ, Huang Y. Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer. Oncogene 2010; 29:2153-9; PMID:20101213; http://dx.doi.org/10.1038/onc.2009.500.
12. Kong D, Banerjee S, Ahmad A, Li Y, Wang Z, Sethi S, et al. Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells. PLoS One 2010; 5:e12445; PMID:20805998; http://dx.doi.org/10.1371/journal.pone.0012445.
13. Wang YC, Chen YL, Yuan RH, Pan HW, Yang WC, Hsu HC, et al. Lin-28B expression promotes transformation and invasion in human hepatocellular carcinoma. Carcinogenesis 2010; 31:1516-22; PMID:20525879; http://dx.doi.org/10. 1093/carcin/bgq107.
14. King CE, Wang L, Winograd R, Madison BB, Mongroo PS, Johnstone CN, et al. LIN28B fosters colon cancer migration, invasion and transformation through let-7-dependent and -independent mechanisms. Oncogene 2011; 30:4185-93; PMID:21625210; http://dx.doi.org/10.1038/onc.2011.131.
15. Helland A, Anglesio MS, George J, Cowin PA, Johnstone CN, House CM, et al.; Australian Ovarian Cancer Study Group. Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers. PLoS One 2011; 6:e18064; PMID:21533284; http://dx.doi.org/10.1371/journal.pone. 0018064.
16. Hamano R, Miyata H, Yamasaki M, Sugimura K, Tanaka K, Kurokawa Y, et al. High expression of Lin28 is associated with tumour aggressiveness and poor prognosis of patients in oesophagus cancer. Br J Cancer 2012; 106:1415-23; PMID:22433967; http://dx.doi.org/10.1038/bjc.2012.90.
17. King CE, Cuatrecasas M, Castells A, Sepulveda AR, Lee JS, Rustgi AK. LIN28B promotes colon cancer progression and metastasis. Cancer Res 2011; 71:4260-8; PMID:21512136; http://dx.doi.org/10.1158/0008-5472.CAN-10-4637.
18. Permuth-Wey J, Kim D, Tsai YY, Lin HY, Chen YA, Barnholtz-Sloan J, et al.; Ovarian Cancer Association Consortium. LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer. Cancer Res 2011; 71:3896-903; PMID:21482675; http://dx.doi.org/10.1158/0008-5472.CAN-10-4167.
19. Chin LJ, Ratner E, Leng S, Zhai R, Nallur S, Babar I, et al. A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. Cancer Res 2008; 68:8535-40; PMID:18922928; http://dx.doi.org/10.1158/0008-5472.CAN-08-2129.
20. Widén E, Ripatti S, Cousminer DL, Surakka I, Lappalainen T, Järvelin MR, et al. Distinct variants at LIN28B influence growth in height from birth to adulthood. Am J Hum Genet 2010; 86:773-82; PMID:20398887; http://dx.doi.org/10.1016/j.ajhg.2010.03.010.
21. Lin M, Gu J, Eng C, Ellis LM, Hildebrandt MA, Lin J, et al. Genetic polymorphisms in MicroRNA-related genes as predictors of clinical outcomes in colorectal adenocarcinoma patients. Clin Cancer Res 2012; 18:3982-91; PMID:22661538; http://dx.doi.org/10.1158/1078-0432.CCR-11-2951.
22. Cicek MS, Slager SL, Achenbach SJ, French AJ, Blair HE, Fink SR, et al. Functional and clinical significance of variants localized to 8q24 in colon cancer. Cancer Epidemiol Biomarkers Prev 2009; 18:2492-500.
23. Huppi K, Pitt JJ, Wahlberg BM, Caplen NJ. The 8q24 gene desert: an oasis of non-coding transcriptional activity. Front Genet 2012; 3:69; PMID:22558003; http://dx.doi.org/10.3389/fgene.2012.00069.
24. Rustgi AK. The geneticcs of hereditary colon cancer. Genes Dev 2007; 21:2525-38; PMID:17938238; http://dx.doi.org/10.1101/gad.1593107.